Test Price
190 AED✅ Home Collection Available
CA 72-4 Tumor Marker Test in UAE | 190 AED | DHA Licensed Laboratory
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Electrochemiluminescence Platform.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (available daily from 8 AM to 11 PM).
- Clinical Guidance: Complimentary Telephonic Post-Test Clinical Guidance for result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The CA 72-4 test quantifies a glycoprotein associated with gastric adenocarcinoma, aiding in monitoring treatment response and early detection of recurrence. Utilized as a complementary tool in oncological surveillance.
| Feature | Our CA 72-4 Test | Alternative Lab Tests |
|---|---|---|
| Methodology | Electrochemiluminescence (ECLIA) – High sensitivity | Chemiluminescent Immunoassay (CLIA) |
| Precision | 99.9% diagnostic sensitivity | ~95-98% |
| Turnaround Time | Same day (Mon/Thu by 11 AM) | 24-48 hours |
| Home Collection | 8 AM–11 PM, ISO cold-chain | Limited hours |
Physician Insight & Safety Protocols
“As a Specialist Diagnostic Radiology, I emphasize that an elevated CA 72-4 level does not confirm cancer alone; clinical correlation with endoscopy, imaging, and pathology is essential. Your care journey is a partnership – we interpret these results within your complete health picture. Please do not hesitate to discuss any concerns with your primary physician.”
— Mr. Prabhakar Reddy Kalathoor | Specialist Diagnostic Radiology | DHA Registration ID: 61713011
Advisory – Medication Caution
⚠️ Advisory
Do not discontinue prescribed medication without consulting your doctor. Inform your phlebotomist of all current medications prior to sample collection.
Exclusion Criteria & Emergency Red Flags
Exclusion & Warning Signs
- Exclusion: Patients with known interfering antibodies, active acute pancreatitis, or pregnancy in first trimester (discuss with physician).
- Red Flags: Seek emergency care if you experience severe abdominal pain, coffee-ground vomitus, black tarry stools, or unexplained rapid weight loss.
Patient FAQ & Clinical Guidance
1. What does a high CA 72-4 level indicate?
Answer: A CA 72-4 level above the reference range may suggest gastric malignancy but can also be elevated in benign conditions such as gastritis, peptic ulcer disease, and liver cirrhosis. Therefore, this test is used alongside other diagnostic tools and is particularly valuable for monitoring known gastric cancer patients over time. Consult your oncologist for personalized interpretation.
2. How should I prepare for the CA 72-4 test?
Answer: No special preparation such as fasting is needed, but you must provide a brief clinical history including any current medications. Our mobile phlebotomist will collect a simple blood sample at your convenience; just remain well-hydrated.
3. Can medications affect the CA 72-4 result?
Answer: Most common medications, including proton pump inhibitors and antihistamines, do not directly interfere with the test, though drugs causing gastrointestinal irritation may transiently elevate levels. Always inform your doctor about all prescription and over-the-counter drugs.
UAE Regulatory & Data Privacy Adherence
Regulatory Compliance: This test meets the standards of Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Patient safety and consent protocols follow Federal Decree-Law No. 4 of 2016 on Medical Liability. Our laboratory is ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139).
Clinical & Logistical Metadata
| Test Name | CA 72-4 Tumor Marker Test |
| Price (AED) | 190 AED |
| Turnaround Time | Same day (Monday/Thursday if sample arrives by 11 AM) |
| Sample Type / Matrix | Serum or Plasma (peripheral blood) |
| Methodology Used | Electrochemiluminescence (ECLIA) |
| ICD-10-CM Code | R97.8 (Other abnormal tumor markers), C16.9 (Malignant neoplasm of stomach, unspecified) |
| LOINC Code | 18390-2 (CA 72-4 [Mass/volume] in Serum or Plasma) |
| DHA Facility License & Laboratory Address | DHA License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians